A citation-based method for searching scientific literature

Joël Vos, Encarna Gómez-García, Jan C Oosterwijk, Fred H Menko, Reinoud D Stoel, Christi J van Asperen, Anna M Jansen, Anne M Stiggelbout, Aad Tibben. Psychooncology 2012
Times Cited: 48







List of co-cited articles
283 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


The counsellees' view of an unclassified variant in BRCA1/2: recall, interpretation, and impact on life.
Joël Vos, Wilma Otten, Christi van Asperen, Anna Jansen, Fred Menko, Aad Tibben. Psychooncology 2008
81
39

Distress among women receiving uninformative BRCA1/2 results: 12-month outcomes.
Suzanne C O'Neill, Christine Rini, Rachel E Goldsmith, Heiddis Valdimarsdottir, Lawrence H Cohen, Marc D Schwartz. Psychooncology 2009
71
31




Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.
Sue Richards, Nazneen Aziz, Sherri Bale, David Bick, Soma Das, Julie Gastier-Foster, Wayne W Grody, Madhuri Hegde, Elaine Lyon, Elaine Spector,[...]. Genet Med 2015
20

Perceiving cancer-risks and heredity-likelihood in genetic-counseling: how counselees recall and interpret BRCA 1/2-test results.
J Vos, J C Oosterwijk, E Gómez-García, F H Menko, A M Jansen, R D Stoel, C J van Asperen, A Tibben, A M Stiggelbout. Clin Genet 2011
32
28

Exploring the short-term impact of DNA-testing in breast cancer patients: the counselees' perception matters, but the actual BRCA1/2 result does not.
Joël Vos, Jan C Oosterwijk, Encarna Gomez-Garcia, Fred H Menko, Margriet J Collee, Christi J van Asperen, Anna M Jansen, Anne M Stiggelbout, Aad Tibben. Patient Educ Couns 2012
22
40


Variants of unknown significance in BRCA testing: impact on risk perception, worry, prevention and counseling.
S Richter, I Haroun, T C Graham, A Eisen, A Kiss, E Warner. Ann Oncol 2013
60
18

Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies.
A Antoniou, P D P Pharoah, S Narod, H A Risch, J E Eyfjord, J L Hopper, N Loman, H Olsson, O Johannsson, A Borg,[...]. Am J Hum Genet 2003
16

Variants of uncertain significance in BRCA testing: evaluation of surgical decisions, risk perception, and cancer distress.
J O Culver, C D Brinkerhoff, J Clague, K Yang, K E Singh, S R Sand, J N Weitzel. Clin Genet 2013
57
14


A brief assessment of concerns associated with genetic testing for cancer: the Multidimensional Impact of Cancer Risk Assessment (MICRA) questionnaire.
David Cella, Chanita Hughes, Amy Peterman, Chih-Hung Chang, Beth N Peshkin, Marc D Schwartz, Lari Wenzel, Amy Lemke, Alfred C Marcus, Caryn Lerman. Health Psychol 2002
166
12

Impact of Event Scale: a measure of subjective stress.
M Horowitz, N Wilner, W Alvarez. Psychosom Med 1979
12

A systematic review of the impact of genetic counseling on risk perception accuracy.
Chris M R Smerecnik, Ilse Mesters, Eline Verweij, Nanne K de Vries, Hein de Vries. J Genet Couns 2009
83
12

A systematic review of perceived risks, psychological and behavioral impacts of genetic testing.
Jodi T Heshka, Crystal Palleschi, Heather Howley, Brenda Wilson, Philip S Wells. Genet Med 2008
221
12

Clinical characteristics affect the impact of an uninformative DNA test result: the course of worry and distress experienced by women who apply for genetic testing for breast cancer.
Sandra van Dijk, Daniëlle R M Timmermans, Hanne Meijers-Heijboer, Aad Tibben, Christi J van Asperen, Wilma Otten. J Clin Oncol 2006
60
12

Long-term psychosocial outcomes of BRCA1/BRCA2 testing: differences across affected status and risk-reducing surgery choice.
Kristi D Graves, Patti Vegella, Elizabeth A Poggi, Beth N Peshkin, Angie Tong, Claudine Isaacs, Clinton Finch, Scott Kelly, Kathryn L Taylor, George Luta,[...]. Cancer Epidemiol Biomarkers Prev 2012
53
12

Sequence variant classification and reporting: recommendations for improving the interpretation of cancer susceptibility genetic test results.
Sharon E Plon, Diana M Eccles, Douglas Easton, William D Foulkes, Maurizio Genuardi, Marc S Greenblatt, Frans B L Hogervorst, Nicoline Hoogerbrugge, Amanda B Spurdle, Sean V Tavtigian. Hum Mutat 2008
548
12

BRCA1 and BRCA2 genetic testing-pitfalls and recommendations for managing variants of uncertain clinical significance.
D M Eccles, G Mitchell, A N A Monteiro, R Schmutzler, F J Couch, A B Spurdle, E B Gómez-García. Ann Oncol 2015
110
12

Understanding of BRCA VUS genetic results by breast cancer specialists.
B K Eccles, E Copson, T Maishman, J E Abraham, D M Eccles. BMC Cancer 2015
55
12

Psychological outcomes and risk perception after genetic testing and counselling in breast cancer: a systematic review.
Phyllis N Butow, Elizabeth A Lobb, Bettina Meiser, Alexandra Barratt, Katherine M Tucker. Med J Aust 2003
123
10

What do women really want to know? Motives for attending familial breast cancer clinics.
C J Van Asperen, S Van Dijk, M W Zoeteweij, D R M Timmermans, G H De Bock, E J Meijers-Heijboer, M F Niermeijer, M H Breuning, J Kievit, W Otten. J Med Genet 2002
54
10

Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality.
Susan M Domchek, Tara M Friebel, Christian F Singer, D Gareth Evans, Henry T Lynch, Claudine Isaacs, Judy E Garber, Susan L Neuhausen, Ellen Matloff, Rosalind Eeles,[...]. JAMA 2010
831
10

No evidence of false reassurance among women with an inconclusive BRCA1/2 genetic test result.
Michel Dorval, Geneviève Gauthier, Elizabeth Maunsell, Michel J Dugas, Isabelle Rouleau, Jocelyne Chiquette, Marie Plante, Rachel Laframboise, Michel Gaudet, Peter J Bridge,[...]. Cancer Epidemiol Biomarkers Prev 2005
39
12

The trajectory of psychological impact in BRCA1/2 genetic testing: does time heal?
Tammy M Beran, Annette L Stanton, Lorna Kwan, Joyce Seldon, Julienne E Bower, Andrea Vodermaier, Patricia A Ganz. Ann Behav Med 2008
52
10

A counselee-oriented perspective on risk communication in genetic counseling: explaining the inaccuracy of the counselees' risk perception shortly after BRCA1/2 test result disclosure.
Joël Vos, Anne M Stiggelbout, Jan Oosterwijk, Encarna Gomez-Garcia, Fred Menko, J Margriet Collee, Christi J van Asperen, Aad Tibben. Genet Med 2011
15
33

Long-term reactions to genetic testing for BRCA1 and BRCA2 mutations: does time heal women's concerns?
Chanita Hughes Halbert, Jill E Stopfer, Jasmine McDonald, Benita Weathers, Aliya Collier, Andrea B Troxel, Susan Domchek. J Clin Oncol 2011
50
10

Variants of uncertain clinical significance as a result of BRCA1/2 testing: impact of an ambiguous breast cancer risk message.
Sandra van Dijk, Christi J van Asperen, Catharina E Jacobi, Geraldine R Vink, Aad Tibben, Martijn H Breuning, Wilma Otten. Genet Test 2004
32
15

A review of a multifactorial probability-based model for classification of BRCA1 and BRCA2 variants of uncertain significance (VUS).
Noralane M Lindor, Lucia Guidugli, Xianshu Wang, Maxime P Vallée, Alvaro N A Monteiro, Sean Tavtigian, David E Goldgar, Fergus J Couch. Hum Mutat 2012
140
10

BRCA1/2 sequence variants of uncertain significance: a primer for providers to assist in discussions and in medical management.
Noralane M Lindor, David E Goldgar, Sean V Tavtigian, Sharon E Plon, Fergus J Couch. Oncologist 2013
58
10

A preliminary investigation of genetic counselors' information needs when receiving a variant of uncertain significance result: a mixed methods study.
Courtney L Scherr, Noralane M Lindor, Teri L Malo, Fergus J Couch, Susan T Vadaparampil. Genet Med 2015
18
27

Multiplex genetic testing for cancer susceptibility: out on the high wire without a net?
Susan M Domchek, Angela Bradbury, Judy E Garber, Kenneth Offit, Mark E Robson. J Clin Oncol 2013
157
10

A comprehensive laboratory-based program for classification of variants of uncertain significance in hereditary cancer genes.
J M Eggington, K R Bowles, K Moyes, S Manley, L Esterling, S Sizemore, E Rosenthal, A Theisen, J Saam, C Arnell,[...]. Clin Genet 2014
116
10

Gene-panel sequencing and the prediction of breast-cancer risk.
Douglas F Easton, Paul D P Pharoah, Antonis C Antoniou, Marc Tischkowitz, Sean V Tavtigian, Katherine L Nathanson, Peter Devilee, Alfons Meindl, Fergus J Couch, Melissa Southey,[...]. N Engl J Med 2015
491
10


Lynch Syndrome Limbo: Patient Understanding of Variants of Uncertain Significance.
Ilana Solomon, Elizabeth Harrington, Gillian Hooker, Lori Erby, Jennifer Axilbund, Heather Hampel, Kara Semotiuk, Amie Blanco, William M P Klein, Francis Giardiello,[...]. J Genet Couns 2017
28
17

Psychological consequences of predictive genetic testing: a systematic review.
M Broadstock, S Michie, T Marteau. Eur J Hum Genet 2000
235
8

Family communication matters: the impact of telling relatives about unclassified variants and uninformative DNA-test results.
Joël Vos, Anna M Jansen, Fred Menko, Christi J van Asperen, Anne M Stiggelbout, Aad Tibben. Genet Med 2011
26
15


Genetic uptake in BRCA-mutation families is related to emotional and behavioral communication characteristics of index patients.
Karin Landsbergen, Chris Verhaak, Floor Kraaimaat, Nicoline Hoogerbrugge. Fam Cancer 2005
53
8

Family system characteristics and psychological adjustment to cancer susceptibility genetic testing: a prospective study.
I van Oostrom, H Meijers-Heijboer, H J Duivenvoorden, A H J T Bröcker-Vriends, C J van Asperen, R H Sijmons, C Seynaeve, A R van Gool, J G M Klijn, A Tibben. Clin Genet 2007
55
8

Psychological side effects of breast cancer screening.
C Lerman, B Trock, B K Rimer, C Jepson, D Brody, A Boyce. Health Psychol 1991
389
8


Feeling at risk: how women interpret their familial breast cancer risk.
Sandra van Dijk, Wilma Otten, Christi J van Asperen, Danielle R M Timmermans, Aad Tibben, Moniek W Zoeteweij, Sylvia Silberg, Martijn H Breuning, Job Kievit. Am J Med Genet A 2004
25
16

A new definition of Genetic Counseling: National Society of Genetic Counselors' Task Force report.
Robert Resta, Barbara Bowles Biesecker, Robin L Bennett, Sandra Blum, Susan Estabrooks Hahn, Michelle N Strecker, Janet L Williams. J Genet Couns 2006
365
8


What's the message? Interpretation of an uninformative BRCA1/2 test result for women at risk of familial breast cancer.
Sandra van Dijk, Wilma Otten, Daniëlle R M Timmermans, Christi J van Asperen, Hanne Meijers-Heijboer, Aad Tibben, Martijn H Breuning, Job Kievit. Genet Med 2005
42
9

Psychological distress and quality of life associated with genetic testing for breast cancer risk.
Ashley Wilder Smith, Angela Liegey Dougall, Donna M Posluszny, Tamara J Somers, Wendy S Rubinstein, Andrew Baum. Psychooncology 2008
50
8


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.